Cvs Health Sore Throat Fast Relief Oral Anesthetic

Phenol


Cvs Pharmacy,inc.
Human Otc Drug
NDC 59779-895
Cvs Health Sore Throat Fast Relief Oral Anesthetic also known as Phenol is a human otc drug labeled by 'Cvs Pharmacy,inc.'. National Drug Code (NDC) number for Cvs Health Sore Throat Fast Relief Oral Anesthetic is 59779-895. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Cvs Health Sore Throat Fast Relief Oral Anesthetic drug includes Phenol - 1.4 g/100mL . The currest status of Cvs Health Sore Throat Fast Relief Oral Anesthetic drug is Active.

Drug Information:

Drug NDC: 59779-895
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Cvs Health Sore Throat Fast Relief Oral Anesthetic
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Phenol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Cvs Pharmacy,inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:PHENOL - 1.4 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 18 Aug, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part356
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:CVS Pharmacy,Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:198776
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0050428435489
UPC stands for Universal Product Code.
UNII:339NCG44TV
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
59779-895-06177 mL in 1 BOTTLE, SPRAY (59779-895-06)18 Aug, 2015N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose oral anesthetic/analgesic

Product Elements:

Cvs health sore throat fast relief oral anesthetic phenol phenol phenol fd&c red no. 40 glycerin water sucralose

Indications and Usage:

Uses for the temporary relief of occasional minor irritation, pain, sore mouth and sore throat.

Warnings:

Warnings sore throat warning: severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. consult doctor promptly. do not use more than 2 days or administer to children under 6 years of age unless directed by doctor. when using this product, do not exceed recommended dosage. stop use and ask a doctor or dentist if ? sore mouth symptoms do not improve in 7 days ? irritation, pain or redness persists or worsens ? swelling, rash or fever develops if pregnant or breast-feeding, ask a doctor before use. keep out of reach of children. in case of overdose or accidental poisoning, get medical help or contact a poison control center right away (1-800-222-1222).

When Using:

When using this product, do not exceed recommended dosage.

Dosage and Administration:

Directions adults and children 6 years of age and older: ? apply to the affected area (one spray) ? allow to remain in place for at least 15 seconds, then spit out ? use every 2 hours or as directed by a doctor or dentist children under 12 years of age should be supervised in the use of this product

Stop Use:

Stop use and ask a doctor or dentist if ? sore mouth symptoms do not improve in 7 days ? irritation, pain or redness persists or worsens ? swelling, rash or fever develops

Package Label Principal Display Panel:

Principal display panel cvs health ™ *compare to active ingredient in chloraseptic ® * sore throat spray phenol oral anesthetic fast relief • fast acting sore throat relief • sugar, gluten & aspirin free alcohol-free cherry flavor naturally and artificially flavored 6 fl oz (177 ml) *this product is not manufactured or distributed by medtech products inc., a prestige brands co., distributor of chloraseptic ® tamper-evident: do not use if imprinted shrink band is broken or missing. distributed by: cvs pharmacy, inc. one cvs drive, woonsocket, ri 02895 ©2018 cvs /pharmacy cvs.com 1-800-shop cvs made in the u.s.a. v-12431 cvs quality money back guarantee cvs health sore throat spray cherry flavor

Further Questions:

Questions or comments? 1-866-467-2748 aspirin-free? sugar-free ?gluten-free ?alcohol-free


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.